Afferent Pharmaceuticals

Afferent Pharmaceuticals

Verified
Clinical-stage biopharmaceutical company that develops medicines to treat chronic pain
  • Edit
DateInvestorsAmountRound
N/A$150kConvertible
$23mSeries A
N/A$5mEarly VC
N/A$5mEarly VC
$55mSeries C
$1.3bAcquisition
Total Funding$88.2m

Recent News about Afferent Pharmaceuticals

Edit